AR HB1269

Adds definitions for "biological product" and "interchangeable biological product" to Arkansas pharmacy law, referencing federal definitions under 42 U.S.C. 262(i).

Permits pharmacists to substitute interchangeable biological products for brand-name biological products when there is cost savings for the patient, with patient disclosure of savings upon request.

Prohibits pharmacist substitution if the prescriber indicates no substitution in writing, expressly communicates no substitution, the patient requests no substitution, or the Arkansas State Board of Pharmacy determines the product should not be substituted.

Requires pharmacists to record specific interchangeable biological products dispensed within five business days, including product name and manufacturer, and maintain records for two years with electronic accessibility to prescribers through multiple systems.

Directs the Arkansas State Board of Pharmacy to maintain a website link to all interchangeable biological products approved by the U.S. Food and Drug Administration.